INDO AMINES LIMITED
INDOAMIN · General/Diversified · NSE
₹114
Current Market Price
Fair Value (DCF)
₹129
Margin of Safety
+13.2%
Updated 2d ago
YieldIQ Score
52/100
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
25%
ROE
—
Debt/Equity
0.85
WACC
11.1%
Market Cap
₹830 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
24.0%
Return on capital employed
EV / EBITDA
9.6×
Enterprise multiple
Debt / EBITDA
2.4×
Leverage vs earnings
Interest Coverage
4.4×
EBIT covers interest
Current Ratio
1.26×
Short-term liquidity
Asset Turnover
1.39×
Revenue per ₹ of assets
Revenue CAGR (3Y)
11.5%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹114.36
Bear case
₹71.06
MoS -60.9%
Base case
₹129.44
MoS +11.7%
Bull case
₹172.19
MoS +33.6%
Ratio Trends
INDOAMIN · last 4 annual periods
ROE
17.4%
ROCE
19.3%
Operating Margin
—
Debt / Equity
0.90×
PE
13.7×
EV / EBITDA
8.8×
Historical Financials
INDOAMIN · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹786 Cr | ₹235 Cr | ₹253 Cr | ₹1079 Cr | +11.1% |
| EBITDA | ₹60.5 Cr | ₹89.0 Cr | ₹93.9 Cr | ₹116 Cr | +24.4% |
| EBIT | ₹48.5 Cr | ₹28.5 Cr | ₹17.7 Cr | — | -28.6% |
| PAT | ₹23.0 Cr | ₹17.1 Cr | ₹9.1 Cr | ₹55.2 Cr | +33.8% |
| EPS (diluted) | ₹3.26 | ₹2.44 | ₹1.32 | — | -26.0% |
| CFO | ₹35.2 Cr | ₹20.4 Cr | ₹69.7 Cr | ₹90.9 Cr | +37.2% |
| CapEx | — | — | — | ₹-91.4 Cr | — |
| FCF | — | — | — | ₹-0.5 Cr | — |
| Total Assets | ₹554 Cr | ₹597 Cr | ₹633 Cr | ₹779 Cr | +12.0% |
| Total Debt | — | ₹174 Cr | ₹157 Cr | ₹284 Cr | +17.8% |
| Shareholders' Equity | — | ₹225 Cr | ₹263 Cr | ₹318 Cr | +12.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
INDOAMIN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SRHHYPOLTD SRHHYPOLTD | — | — | Pending | 9.7% | — |
| INDOBORAX INDOBORAX | — | — | Pending | 12.7% | — |
| VALIANTORG VALIANTORG | — | — | Pending | -0.5% | — |
| GEMAROMA GEMAROMA | — | — | Pending | 18.8% | — |
| UNIENTER UNIENTER | — | — | Pending | 0.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for INDOAMIN in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of INDOAMIN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for INDOAMIN →
Compare
Head-to-head with peers
Compare INDOAMIN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse INDOAMINNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.